| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.4986 | 20 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.1633 | 33 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.3077 | 10 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.4514 | 15 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.2734 | 14 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.7489 | 16 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.32 | 42 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.9447 | 36 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.162 | 18 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.0727 | 41 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.4068 | 19 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.3102 | 24 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.4315 | 43 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.9694 | 32 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 40.8396 | 9 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.6761 | 25 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.1174 | 42 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 40.988 | 9 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.1584 | 28 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.0344 | 22 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 37.4174 | 2 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 42.9582 | 17 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.1219 | 23 |